Amneal Pharmaceuticals Announces Restructuring and Costs Savings Plan to Improve Operations and Position the Company for Future Growth
‒ Plan expected to reduce costs by approximately $50 million annually ‒ ‒ Reduces Full Year 2019 Adjusted EBITDA Guidance…